Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug

Authorized generics are identical in formulation to brand drugs, manufactured by the brand company but marketed as a generic. Generics, marketed by generic manufacturers, are required to demonstrate pharmaceutical and bioequivalence to the brand drug, but repetition of clinical trials is not require...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Pharmacol Ther
Hlavní autoři: Hansen, Richard A., Qian, Jingjing, Berg, Richard L., Linneman, James G., Seoane-Vazquez, Enrique, Dutcher, Sarah, Raofi, Saeid, Page, C. David, Peissig, Peggy L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5860648/
https://ncbi.nlm.nih.gov/pubmed/27981563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.591
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky